Elisa Act Act

ACT

EF018136 96 Tests
EUR 826.8

Elisa Act Laboratories manufactures the elisa act act reagents distributed by Genprice. The Elisa Act Act reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact elisa act. Other Elisa products are available in stock. Specificity: Elisa Category: Act Group: Act

ACT antibody

100 ug
EUR 280
Description: Affinity purified Rabbit polyclonal ACT antibody

ACT-389949

25.0mg
EUR 850

ACT Antibody

0.2mg Ask for price
Description: Recombinant Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) (Yeast) (Candida sphaerica) ACT protein

ACT Antibody

10mg Ask for price
Description: Recombinant Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) (Yeast) (Candida sphaerica) ACT protein

ACT Antibody

0.2mg Ask for price
Description: Recombinant Arabidopsis thaliana ACT protein

ACT Antibody

10mg Ask for price
Description: Recombinant Arabidopsis thaliana ACT protein

ACT-132577

10 mg
EUR 616
Description: ETA/ETB receptors antagonist

Act information

ACT-678689

MBS131416-100mg 100mg
EUR 1495

ACT-678689

HY-19572 1mg
EUR 405.85
Description: ACT-678689 (Compound Example 1.53.4) is a tryptophan hydroxylase (TPH) inhibitor with an IC50 of 8 nM[1].

ACT-373898

HY-135500 10mg Ask for price
Description: ACT-373898 is an inactive carboxylic acid metabolite of Macitentan. Macitentan is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist[1].

ACT-462206

HY-101834 10 mg
EUR 616.89
Description: ACT-462206 is an orally active and potent dual Orexin 1/Orexin 2 receptor antagonist with IC50s of 60 nM (Orexin 1) and 11 nM (Orexin 2), respectively. ACT-462206 exhibits brain penetration properties, and can be used for insomnia, stress/anxiety-related disorders and addiction research[1].

ACT-335827

HY-108683 5 mg
EUR 790.06
Description: ACT-335827 is a selective, orally active, brain-penetrant orexin type 1 receptor antagonist. ACT-33582 acts on OXR1 and OXR2 with IC50 values of 6 nM and 417 nM, respectively. ACT-33582 can be used in studies related to neurological disorders[1].

ACT-451840

HY-111817 10 mg
EUR 1461.06
Description: ACT-451840 is an orally active, potent and low-toxicity compound, showing activity against sensitive and resistant plasmodium falciparum strains. ACT-451840 targets all asexual blood stages of the parasite, has a rapid onset of action. ACT-451840 behaves in a way similar to artemisinin derivatives, with very rapid onset of action and elimination of parasite. ACT-451840 can be used for the research of malarial[1][2][3].

ACT-209905

HY-12616 Get quote Ask for price
Description: ACT-209905 is a S1P1 receptor agonist. ACT-209905 can inhibit glioblastoma (GBM) cell growth and migration. ACT-209905 also has immunomodulating activity, and can be used in research of autoimmune diseases[1].

ACT-389949

HY-124071 1 mg
EUR 1785.74
Description: ACT-389949 is a first-in-class, potent and selective and agonist of formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX), with an EC50 of 3 nM for FPR2/ALX internalization into monocytes. ACT-389949 has potential for the treatment of inflammatory disorders[1][2].

ACT-777991

HY-149055 Get quote Ask for price
Description: ACT-777991 is an orally active and selective CXCR3 antagonist. ACT-777991 has microsomes and hepatocytes stability across animal models. ACT-777991 inhibits the migration of activated T cells toward CXCL11[1].

ACT-606559

HY-141621 Get quote Ask for price
Description: ACT-606559, a new chemical entity with antimalarial activity, is a metabolite of ACT451840. ACT-606559 can be used for the research of malarial[1].

ACT-209905

MBS5776286-5mg 5(mg
EUR 915

ACT-209905

MBS5776286-5x5mg 5x5(mg
EUR 3970

ACT-387042

MBS5776287-5mg 5(mg
EUR 915

ACT-387042

MBS5776287-5x5mg 5x5(mg
EUR 3970

ACT-462206

MBS5776288-10mg 10(mg
EUR 360

ACT-462206

MBS5776288-50mg 50mg
EUR 1400

ACT-462206

MBS5776288-5x50mg 5x50mg
EUR 6155